In addition to the APC mutation, an AXIN2 mutation is also common in CRC
This surprising result raises the possibility that iron bioavailability is, in fact, limiting in AD
Considerations No clinical validation: There is no evidence-based guidance on what is safe or effective in humans
Our advanced vitamin injection therapies are designed to boost energy, enhance wellness, and support overall health
Weeks 4-6: Inject every 14 days
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies